Background: Immunotherapy is an emerging antitumor therapy that can improve the survival of patients with advanced non-small-cell lung cancer (NSCLC). However. only about 20% of NSCLC patients can benefit from this treatment. At present. https://www.sportsplazanyes.shop/product-category/mens-pants-2/